ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 148,22
0,09%
DAX
18 155,24
-0,04%
Brent Oil
84,515
0,39%
Bitcoin
61 139,84
-1,09%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Predictive Oncology Inc (POAI)

  7. Predictive Oncology Inc (POAI) Actualités

POAI

Predictive Oncology (POAI)

Predictive Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:POAI
DateHeureSourceTitreSymboleSociété
22/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:POAIPredictive Oncology Inc
21/05/202421h39Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:POAIPredictive Oncology Inc
15/05/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:POAIPredictive Oncology Inc
14/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:POAIPredictive Oncology Inc
07/12/202314h54Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:POAIPredictive Oncology Inc
05/12/202322h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:POAIPredictive Oncology Inc
04/10/202323h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:POAIPredictive Oncology Inc
15/05/202323h15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:POAIPredictive Oncology Inc
13/05/202300h42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:POAIPredictive Oncology Inc
02/05/202323h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:POAIPredictive Oncology Inc
18/04/202312h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:POAIPredictive Oncology Inc
18/04/202300h00GlobeNewswire Inc.Predictive Oncology Adjourns Special Meeting of StockholdersNASDAQ:POAIPredictive Oncology Inc
05/04/202319h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:POAIPredictive Oncology Inc
29/03/202323h06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:POAIPredictive Oncology Inc
17/03/202322h11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:POAIPredictive Oncology Inc
16/03/202322h15GlobeNewswire Inc.Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common StockNASDAQ:POAIPredictive Oncology Inc
16/03/202322h11Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:POAIPredictive Oncology Inc
09/03/202314h30GlobeNewswire Inc.Predictive Oncology Issues Letter to ShareholdersNASDAQ:POAIPredictive Oncology Inc
28/02/202323h31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:POAIPredictive Oncology Inc
23/02/202314h30GlobeNewswire Inc.Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligenceNASDAQ:POAIPredictive Oncology Inc
21/02/202314h30GlobeNewswire Inc.Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiativesNASDAQ:POAIPredictive Oncology Inc
03/02/202314h31GlobeNewswire Inc.Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business OfficerNASDAQ:POAIPredictive Oncology Inc
12/01/202314h30GlobeNewswire Inc.Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
13/12/202214h30GlobeNewswire Inc.Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
05/12/202214h30GlobeNewswire Inc.Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of DirectorsNASDAQ:POAIPredictive Oncology Inc
10/11/202223h15GlobeNewswire Inc.Predictive Oncology Reports Third Quarter Financial ResultsNASDAQ:POAIPredictive Oncology Inc
25/10/202214h30GlobeNewswire Inc.David S. Smith appointed to the Board of Directors of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
20/10/202214h30GlobeNewswire Inc.Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company GrowthNASDAQ:POAIPredictive Oncology Inc
14/10/202212h08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:POAIPredictive Oncology Inc
13/10/202223h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:POAIPredictive Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:POAI

Dernières Valeurs Consultées

XE
HXCK
Ernst Russ
TG
3RI
Turmalina Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés